Crunchbase News | Serena, Obvious Ventures Invest In This Clinical Trial Marketplace’s $14M Series A

Inato wants to make clinical trials, which often tackle the most complex of diseases, more inclusive of all patients. The startup, founded in 2016 in Paris, France, has raised $14 million in a Series A, led by Obvious Ventures and Cathay Innovation. Serena and Fly Ventures participated in the round as well.